AN2 Historical Income Statement
| ANTX Stock | USD 1.67 0.30 21.90% |
Historical analysis of AN2 Therapeutics income statement accounts such as Interest Expense of 620.7 K, Selling General Administrative of 7.7 M or Selling And Marketing Expenses of 17.8 M can show how well AN2 Therapeutics performed in making a profits. Evaluating AN2 Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of AN2 Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining AN2 Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AN2 Therapeutics is a good buy for the upcoming year.
AN2 |
About AN2 Income Statement Analysis
AN2 Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to AN2 Therapeutics shareholders. The income statement also shows AN2 investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
AN2 Therapeutics Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of AN2 Therapeutics. It is also known as AN2 Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from AN2 Therapeutics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of AN2 Therapeutics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on AN2 Therapeutics income statement and is an important metric when analyzing AN2 Therapeutics profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most accounts from AN2 Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into AN2 Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AN2 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy AN2 Stock please use our How to Invest in AN2 Therapeutics guide.At this time, AN2 Therapeutics' Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 620.7 K in 2024, whereas Selling General Administrative is likely to drop slightly above 7.7 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 69K | 1.4M | 1.6M | 1.6M | Net Interest Income | 69K | 1.4M | 1.6M | 1.6M |
AN2 Therapeutics income statement Correlations
Click cells to compare fundamentals
AN2 Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for AN2 Stock Analysis
When running AN2 Therapeutics' price analysis, check to measure AN2 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AN2 Therapeutics is operating at the current time. Most of AN2 Therapeutics' value examination focuses on studying past and present price action to predict the probability of AN2 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AN2 Therapeutics' price. Additionally, you may evaluate how the addition of AN2 Therapeutics to your portfolios can decrease your overall portfolio volatility.